{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-24-017455","form_type":"8-K","ticker":null,"cik":"0001098880","company_name":"IntelGenx Technologies Corp.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.662625+00:00","generated_at":"2026-05-30T19:01:46.288927+00:00","sec_items":["2.01","5.02"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"IntelGenx Technologies completes acquisition by atai Life Sciences via credit bid; executives and board resign","bullets":["On Sept 30, 2024, Superior Court of Québec approved a credit-bid acquisition by atai Life Sciences AG of all IntelGenx Corp. shares.","Transaction closed Oct 2, 2024; atai used its senior secured debt as consideration; no cash or equity exchanged.","Shareholders of IntelGenx Technologies will receive no payments; ResidualCo and New ParentCo expected to file for bankruptcy.","CEO Dwight Gorham, CFO Andre Godin, and Corporate Secretary Ingrid Zerbe resigned on Oct 2, 2024.","Entire board including Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-24-017455","json":"https://secwatch.observer/filing/0001062993-24-017455.json","markdown":"https://secwatch.observer/filing/0001062993-24-017455.md","text":"https://secwatch.observer/filing/0001062993-24-017455.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:01:46.288927+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d0a353fbd","claim":"Dwight Gorham resigned as Chief Executive Officer at IntelGenx Technologies Corp..","evidence_excerpt":"O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"5f0ea3b114","claim":"Horst G. Zerbe resigned as Director at IntelGenx Technologies Corp..","evidence_excerpt":"O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the \"Resignations\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"72f22e7f9d","claim":"Dwight Gorham resigned as Director at IntelGenx Technologies Corp..","evidence_excerpt":"O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the \"Resignations\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"9327769ae3","claim":"Mark Nawacki resigned as Director at IntelGenx Technologies Corp..","evidence_excerpt":"O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the \"Resignations\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a754e13442","claim":"Monika Trzcinska resigned as Director at IntelGenx Technologies Corp..","evidence_excerpt":"O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the \"Resignations\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c121ec3207","claim":"Ingrid Zerbe resigned as Corporate Secretary at IntelGenx Technologies Corp..","evidence_excerpt":"O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Corporate Secretary"}],"fact_type":"executive_change"},{"claim_id":"e41fb15260","claim":"Andre Godin resigned as Chief Financial Officer at IntelGenx Technologies Corp..","evidence_excerpt":"O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"f334e1863b","claim":"Bernd J. Melchers resigned as Director at IntelGenx Technologies Corp..","evidence_excerpt":"O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the \"Resignations\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"454334ccbef9c6edc15ca158d5b859bcc0fd22f0","claim":"IntelGenx Technologies Corp. completed a disposition involving atai Life Sciences AG for senior secured debt in the Company was discharged in exchange for IGX shares (closed 2024-10-02).","evidence_excerpt":"Pursuant to the Transaction, which closed on October 2, 2024, atai acquired all of the issued and outstanding shares of IGX.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324017455/0001062993-24-017455-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"atai Life Sciences AG"},{"label":"Consideration","value":"senior secured debt in the Company was discharged in exchange for IGX shares"},{"label":"Closing","value":"2024-10-02"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}